Rich Apothecary, Inc., et al v. OptumRx, Inc.
| RICH APOTHECARY, INC., doing business as Lake Elmo Pharmacy and D&K PHARMACY, INC., doing business as Keaveny Drug |
| OPTUMRX, INC., as corporate successor to Catamaran Corporation |
| 26-1879 |
| April 24, 2026 |
| U.S. Court of Appeals, Seventh Circuit |
| Other Contract Actions |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 17, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 24 Motion filed by Appellees D&K Pharmacy, Inc. and Rich Apothecary, Inc. to extend time to file appellee brief. [24] [7533709] [26-1879] (Tauger, Debra) [Entered: 06/17/2026 02:43 PM] |
| Filing 23 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Michael Rubin for Appellees D&K Pharmacy, Inc. and Rich Apothecary, Inc.. [23] [7533035] (L-No; E-Yes; R-No) [26-1879] (Boxer, Joshua) [Entered: 06/15/2026 07:17 PM] |
| Filing 22 Filed Notice of Association of Counsel for Appellees by Appellees D&K Pharmacy, Inc. and Rich Apothecary, Inc.. [22] [7533033] [26-1879]--[Edited 06/17/2026 by FP to reflect that atty. Rubin is added to the docket.] (Boxer, Joshua) [Entered: 06/15/2026 07:08 PM] |
| Filing 21 Amended Jurisdictional Statement filed by Appellant OptumRx, Inc. [21] [7532909] [26-1879] (JAD) [Entered: 06/15/2026 02:08 PM] |
| Filing 20 Added Attorney(s) Peter S. Lubin for party(s) Appellee Rich Apothecary, Inc. Appellee D&K Pharmacy, Inc., in case 26-1879 per disclosure statement. Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Peter S. Lubin for Appellees Rich Apothecary, Inc. and D&K Pharmacy, Inc. [20] [7532310] (L-No; E-Yes; R-No) [26-1879]--[Edited 06/11/2026 by AD to reflect the addition of counsel.] (Lubin, Peter) [Entered: 06/11/2026 02:33 PM] |
| Filing 19 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Thomas H. Dupree, Jr. for Appellant OptumRx, Inc. [19] [7532271] (L-No; E-Yes; R-No) [26-1879] [19] [7532271] [26-1879]--[Edited 06/11/2026 by HTP to reflect addition of counsel.] (Dupree, Thomas) [Entered: 06/11/2026 01:16 PM] |
| Filing 18 Paper copies of appellant brief and appendix (vol. I-III) filed by Appellant OptumRx, Inc.. [18] [7531835] [26-1879] (SK) [Entered: 06/10/2026 10:35 AM] |
| Filing 17 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Debra J. Tauger for Appellees D&K Pharmacy, Inc. and Rich Apothecary, Inc. [17] [7531754] (L-No; E-Yes; R-No) [26-1879]--[Docket updated 06/10/2026 by JR to add Attorney Tauger.] (Tauger, Debra) [Entered: 06/09/2026 06:36 PM] |
| Filing 16 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Joshua D. Boxer for Appellees Rich Apothecary, Inc. and D&K Pharmacy, Inc. [16] [7531753] (L-Yes; E-Yes; R-No) [26-1879] (Boxer, Joshua) [Entered: 06/09/2026 06:23 PM] |
Filing 15
ORDER: Appellant shall file an amended jurisdictional statement on or before June 15, 2026, that provides the omitted information noted in this order and otherwise complies with all the requirements of Rule 28(a)(4) of the Federal Rules of Appellate Procedure and Circuit Rule 28(a). The Clerk shall DISTRIBUTE, along with the briefs in this appeal, copies of this order and the "Amended Jurisdictional Statement" to the assigned merits panel. (See order for further details) JXK [15] [7531089] [26-1879] (PS) [Entered: 06/08/2026 10:31 AM]
|
| Filing 14 Filed Appendix by Appellant OptumRx, Inc. [14] [7530393] Paper copies due on 06/10/2026 [26-1879] (NHV) [Entered: 06/04/2026 08:47 AM] |
| Filing 13 Appellant's brief filed by Appellant OptumRx, Inc. Appellee's brief due on or before 07/06/2026 for D&K Pharmacy, Inc. and Rich Apothecary, Inc.. Paper copies due on 06/10/2026. REMINDER: If a case is designated to proceed to oral argument, hearing notices will be mailed shortly before the date of oral argument. Please note that counsel's unavailability for oral argument must be submitted by letter, filed electronically with the Clerk's Office, and should be made by no later than seven days after the filing of the appellee's brief. See Cir. R. 34(b)(3), (4). The court's calendar is located at https://www.ca7.uscourts.gov/cal/argcalendar.pdf. Once scheduled, oral argument is rescheduled only in extraordinary circumstances. See Cir. R. 34(b)(4), (e). [13] [7530391] [26-1879] (NHV) [Entered: 06/04/2026 08:45 AM] |
| Filing 12 Submitted Appendix by Michael Holecek for Appellant OptumRx, Inc.. [12] NOTE: Access to this entry is limited to counsel of record. Once the document is approved by the court, it will be filed onto the court's docket as a separate entry which will be open to the public. [7530354] [26-1879] (Holecek, Michael) [Entered: 06/03/2026 04:45 PM] |
| Filing 11 Submitted appellant brief by Michael Holecek for Appellant OptumRx, Inc.. [11] NOTE: Access to this entry is limited to counsel of record. Once the document is approved by the court, it will be filed onto the court's docket as a separate entry which will be open to the public. [7530348] [26-1879] (Holecek, Michael) [Entered: 06/03/2026 04:23 PM] |
| Filing 10 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Joseph A. Gorman for Appellant OptumRx, Inc.. [10] [7524366] (L-No; E-Yes; R-No) [26-1879]--[Edited 05/08/2026 by FP to reflect that atty. Gorman is added to the docket.] (Gorman, Joseph) [Entered: 05/08/2026 03:44 PM] |
| Filing 9 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Jarrett H. Gross for Appellant OptumRx, Inc.. [9] [7524175] (L-No; E-Yes; R-No) [26-1879] [Edited 05/08/2026 by CG to reflect the addition of counsel.] (Gross, Jarrett) [Entered: 05/08/2026 10:14 AM] |
| Filing 8 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Kyle D. Rettberg for Appellant OptumRx, Inc.. [8] [7524170] (L-No; E-Yes; R-No) [26-1879] [Edited 05/08/2026 by CG to reflect the addition of counsel.] (Rettberg, Kyle) [Entered: 05/08/2026 10:10 AM] |
| Filing 7 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Scott J. Fisher for Appellant OptumRx, Inc.. [7] [7524166] (L-No; E-Yes; R-No) [26-1879] [Edited 05/08/2026 by CG to reflect the addition of counsel.] (Fisher, Scott) [Entered: 05/08/2026 10:06 AM] |
| Filing 6 Added Attorney(s) Geoffrey Manson Sigler for party(s) Appellant OptumRx, Inc., in case 26-1879 per disclosure statement. Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Geoffrey Sigler for Appellant OptumRx, Inc. [6] [7523364] (L-No; E-Yes; R-No) [26-1879]--[Edited 05/06/2026 by AD to reflect the addition of counsel.] (Sigler, Geoffrey) [Entered: 05/05/2026 03:46 PM] |
| Filing 5 Circuit Rule 26.1 Disclosure Statement and Appearance filed by Attorney Michael Holecek for Appellant OptumRx, Inc.. [5] [7523360] (L-Yes; E-Yes; R-No) [26-1879] (Holecek, Michael) [Entered: 05/05/2026 03:39 PM] |
| Filing 4 NOTICE: Circuit Rule 46(a) requires the lead attorney and any attorney who intends to present oral argument be admitted to practice in this court. The lead attorney for each party represented by counsel must apply for admission to practice in this court by the later of: (a) 30 days from the docketing of the matter in this court; or (b) 15 days from being retained or appointed as counsel. An attorney who intends to present oral argument must apply for admission to practice in this court before the filing of the appellee's brief. Our records indicate Attorney Joshua David Boxer for Appellees Rich Apothecary, Inc. and D&K Pharmacy, Inc. has not been admitted to practice in this court as of this date. The "Application for Admission to Practice in the Seventh Circuit" form can be found at: https://www.ca7.uscourts.gov/assets/pdf/applctn.pdf. The filing of the completed application must be accomplished via the CM/ECF filing system. [4] [7523187] [26-1879] (LJ) [Entered: 05/05/2026 11:31 AM] |
| Filing 3 Amended Jurisdictional Statement filed by Appellant OptumRx, Inc.. [3] [7522870] [26-1879] (Holecek, Michael) [Entered: 05/04/2026 02:56 PM] |
|
Filing 2
ORDER: Circuit Rule 3(c)(1), referencing Circuit Rule 28(a), requires an appellant to file a docketing statement that provides information concerning the district courts jurisdiction and this courts jurisdiction. If jurisdiction depends on diversity, the statement must identify the amount in controversy and establish the required diversity between the parties. Appellant shall file an amended docketing statement that provides a complete statement of jurisdiction that includes corrected information. The statement is due on or before May 4, 2026. (See order for further details). JXK [2] [7520975] [26-1879] (HTP) [Entered: 04/27/2026 02:10 PM]
|
| Filing 1 Private civil case docketed. Fee paid. Docketing statement filed. Transcript information sheet filed. Appellant's brief due on or before 06/03/2026 for OptumRx, Inc. [1] [7520641] [26-1879] (AD) [Entered: 04/24/2026 01:33 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
| Search for this case: Rich Apothecary, Inc., et al v. OptumRx, Inc. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: RICH APOTHECARY, INC., doing business as Lake Elmo Pharmacy | |
| Represented By: | Joshua David Boxer |
| Represented By: | Debra Tauger |
| Represented By: | Peter S. Lubin |
| Represented By: | Michael Rubin |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: D&K PHARMACY, INC., doing business as Keaveny Drug | |
| Represented By: | Joshua David Boxer |
| Represented By: | Debra Tauger |
| Represented By: | Peter S. Lubin |
| Represented By: | Michael Rubin |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: OPTUMRX, INC., as corporate successor to Catamaran Corporation | |
| Represented By: | Michael Holecek |
| Represented By: | Geoffrey Manson Sigler |
| Represented By: | Joseph Abraham Gorman |
| Represented By: | Thomas Henderson Dupree Jr. |
| Represented By: | Kyle D. Rettberg |
| Represented By: | Jarrett H. Gross |
| Represented By: | Scott Jared Fisher |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
